Scientific Exploration of Cryptomeria japonica and Terpinen-4-ol Against Lung Cancer
Explore ResearchLung cancer remains one of the malignancies with the highest incidence and mortality rates worldwide. According to epidemiological surveys, China reported 730,000 new cases and 610,000 deaths from lung cancer in 20155 .
In recent years, phytochemicals have shown tremendous potential in the anticancer field. Research indicates that increased consumption of vegetables and fruits can prevent lung cancer, with various phytochemicals regulating anti-tumor pathways, inhibiting tumor cell proliferation, and inducing tumor cell apoptosis5 . Among numerous plants with anticancer potential, Cryptomeria japonica has attracted particular scientific interest.
Leading cause of cancer death worldwide with over 1.8 million deaths annually
Plant-based therapies have been used in traditional medicine for centuries, and modern science is now validating their efficacy against various cancers.
Cryptomeria japonica is a common coniferous tree widely distributed in East Asia. In traditional medicine, its bark has been used as Chinese medicine for pain relief, treating eczema, rheumatism, and skin inflammation6 . However, modern scientific research has revealed that its value extends far beyond these applications.
In the mid-2000s, researchers isolated a diterpenoid compound named "6-hydroxy-5,6-dehydrosugiol (HDHS)" from the bark of Cryptomeria japonica. Studies found that this compound could inhibit androgen receptor activity in prostate cancer cells and induce cancer cell apoptosis6 . Animal experiments demonstrated that even low doses of HDHS (0.8 mg/kg) effectively inhibited prostate tumor growth without affecting mouse weight or activity, showing no acute toxicity4 .
Cryptomeria japonica, a coniferous tree with significant medicinal potential
Encouraged by the success of Cryptomeria japonica extracts in prostate cancer research, scientists began exploring their effects on lung cancer. In 2010, the National Chung Hsing University Institute of Biomedical Sciences conducted a groundbreaking study investigating the effects of Cryptomeria japonica leaf crude extracts and their bioactive compound terpinen-4-ol on lung cancer cells1 .
The research found that Cryptomeria japonica leaf crude extracts and their bioactive compound terpinen-4-ol could significantly inhibit lung cancer cell proliferation and induce programmed cell death (apoptosis). This effect was validated across multiple lung cancer cell lines, including non-small cell lung cancer A549 and mouse lung cancer LLC2 cells1 .
Terpinen-4-ol is an important active component in Cryptomeria japonica extracts and a natural monoterpene alcohol. It is not only a bioactive compound in Cryptomeria japonica but also the main bioactive component of tea tree oil, constituting 35-48% of tea tree oil7 .
This compound is a colorless or pale yellow oily liquid with spicy, earthy, green, and woody aromas. It is slightly soluble in water but soluble in alcohols and oils, with a boiling point of 212°C or 88-90°C (800Pa)3 .
Research indicates that terpinen-4-ol inhibits lung cancer cells through multiple mechanisms:
Terpinen-4-ol interferes with the normal division cycle of lung cancer cells, arresting them at specific checkpoints to prevent further proliferation.
Activates apoptotic signaling pathways in cancer cells, prompting their self-destruction through mitochondrial pathways.
Affects key signal transduction pathways within cancer cells, reducing expression of proteins critical for cancer cell survival.
Shows strong synergistic effects when combined with conventional chemotherapy drugs, enhancing their anticancer activity.
To better understand the mechanisms by which Cryptomeria japonica extracts combat lung cancer, let's examine the key experiments conducted by Lin Pei-Shan in 20101 .
The experimental results were exciting, revealing multiple mechanisms by which Cryptomeria japonica extracts fight lung cancer:
| Concentration (μg/mL) | A549 Cell Survival Rate (%) | LLC2 Cell Survival Rate (%) |
|---|---|---|
| 0 | 100.0 ± 3.2 | 100.0 ± 4.1 |
| 25 | 78.3 ± 4.5 | 82.6 ± 3.8 |
| 50 | 52.7 ± 3.9 | 57.2 ± 4.3 |
| 100 | 31.5 ± 3.1 | 35.8 ± 3.7 |
| 200 | 18.2 ± 2.8 | 22.4 ± 3.2 |
| Protein Type | Protein Name | Change Trend | Mechanism of Action |
|---|---|---|---|
| Pro-apoptotic | Bax | ↑ | Promotes cytochrome c release from mitochondria |
| Pro-apoptotic | Smac | ↑ | Inhibits apoptosis protein inhibitors (IAPs) |
| Anti-apoptotic | Bcl-2 | ↓ | Reduces inhibition of apoptosis |
| Anti-apoptotic | XIAP | ↓ | Reduces inhibition of caspases |
| Anti-apoptotic | Survivin | ↓ | Reduces inhibition of apoptosis |
Although Cryptomeria japonica extracts and terpinen-4-ol show great potential in lung cancer treatment, several challenges must be addressed before clinical application:
Research on the anti-lung cancer effects of Cryptomeria japonica and its active component terpinen-4-ol demonstrates nature's tremendous potential. These natural compounds inhibit lung cancer cell proliferation, induce apoptosis, and regulate signaling pathways through multiple mechanisms, exhibiting multi-target, low-toxicity characteristics.
With advancing technology and deeper research into natural products, we hope to develop more effective and safer anticancer drugs from natural resources like Cryptomeria japonica, providing new treatment options for lung cancer patients. Nature remains an important source of human medical treasures, waiting for us to explore and discover.